Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant declines » significant decline (Expand Search), significantly declined (Expand Search), significant genes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant declines » significant decline (Expand Search), significantly declined (Expand Search), significant genes (Expand Search)
-
581
-
582
-
583
Temporal changes of older adults’ health level in the Yangtze River Economic Belt.
Published 2024Subjects: -
584
-
585
-
586
Indicators and data sources for the health level and influencing factors of older adults.
Published 2024Subjects: -
587
-
588
Johnsen testicular biopsy score.
Published 2025“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”
-
589
Nanoparticle tracking analysis.
Published 2025“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”
-
590
Sperm count and motility.
Published 2025“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”
-
591
Primer sequences used for RT-PCR.
Published 2025“…Notably, SIRT1 levels decrease with age in both mice and during cellular senescence, highlighting its significance in anti-aging processes. …”
-
592
-
593
Study flow chart.
Published 2025“…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
-
594
Bar graph showing proportion of NADCs.
Published 2025“…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
-
595
Baseline characteristics of study participants.
Published 2025“…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
-
596
The sequences of si-RNAs used in this study.
Published 2024“…Our study observed a significant increase in CRNN expression in cSCC samples compared to healthy skin. …”
-
597
-
598
-
599
-
600